CBWTF (Auxly Cannabis Group) EBIT: $27.1 Mil (TTM As of Mar. 2026)


CBWTF Auxly Cannabis Group Inc CBWTF
36 GF Score
Price $0.12
GF Value $0.03
Valuation Significantly Overvalued
! 4 Warning Signs
View Full Analysis

What is Auxly Cannabis Group EBIT?

Auxly Cannabis Group CBWTF -3.85% 36 EBIT is $27.1 Mil as of Mar. 2026. GuruFocus rates CBWTF with a GF Score™ of 36/100 and a GF Value™ of $0.03 (Significantly Overvalued). The stock has 4 warning signs investors should review.

Auxly Cannabis Group's earnings before interest and taxes (EBIT) for the three months ended in Mar. 2026 was $3.3 Mil. Its earnings before interest and taxes (EBIT) for the trailing twelve months (TTM) ended in Mar. 2026 was $27.1 Mil.

EBIT or Operating Income is linked to Return on Capital for both regular definition and Joel Greenblatt's definition. Auxly Cannabis Group's annualized ROC % for the quarter that ended in Mar. 2026 was 9.42%. Auxly Cannabis Group's annualized ROC (Joel Greenblatt) % for the quarter that ended in Mar. 2026 was 10.77%.

EBIT is also linked to Joel Greenblatt's definition of earnings yield. Auxly Cannabis Group's Earnings Yield (Joel Greenblatt) % for the quarter that ended in Mar. 2026 was 14.57%.

Auxly Cannabis Group  (OTCPK:CBWTF) EBIT Explanation

1. EBIT or Operating Income is linked to Return on Capital for both regular definition and Joel Greenblatt's definition.

Auxly Cannabis Group's annualized ROC % for the quarter that ended in Mar. 2026 is calculated as:

ROC % (Q: Mar. 2026 )
=NOPAT/Average Invested Capital
=Operating Income * ( 1 - Tax Rate % )/( (Invested Capital (Q: Dec. 2025 ) + Invested Capital (Q: Mar. 2026 ))/ count )
=13.692 * ( 1 - 0% )/( (147.267 + 143.398)/ 2 )
=13.692/145.3325
=9.42 %

where

Invested Capital(Q: Dec. 2025 )
=Total Assets - Accounts Payable & Accrued Expense - Excess Cash
=Total Assets - Accounts Payable & Accrued Expense - ( Cash, Cash Equivalents, Marketable Securities - max(0, Total Current Liabilities - Total Current Assets+Cash, Cash Equivalents, Marketable Securities))
=196.909 - 26.14 - ( 23.502 - max(0, 32.717 - 71.938+23.502))
=147.267

Invested Capital(Q: Mar. 2026 )
=Total Assets - Accounts Payable & Accrued Expense - Excess Cash
=Total Assets - Accounts Payable & Accrued Expense - ( Cash, Cash Equivalents, Marketable Securities - max(0, Total Current Liabilities - Total Current Assets+Cash, Cash Equivalents, Marketable Securities))
=203.85 - 29.252 - ( 31.2 - max(0, 35.673 - 79.552+31.2))
=143.398

Note: The Operating Income data used here is four times the quarterly (Mar. 2026) data.

2. Joel Greenblatt's definition of Return on Capital:

Auxly Cannabis Group's annualized ROC (Joel Greenblatt) % for the quarter that ended in Mar. 2026 is calculated as:

ROC (Joel Greenblatt) %(Q: Mar. 2026 )
=EBIT/Average of (Net fixed Assets + Net Working Capital)
=EBIT/Average of (Property, Plant and Equipment+Net Working Capital)
     Q: Dec. 2025  Q: Mar. 2026
=EBIT/( ( (Property, Plant and Equipment + Net Working Capital) + (Property, Plant and Equipment + Net Working Capital) )/ count )
=13.288/( ( (104.122 + max(20.896, 0)) + (103.624 + max(18.025, 0)) )/ 2 )
=13.288/( ( 125.018 + 121.649 )/ 2 )
=13.288/123.3335
=10.77 %

where Working Capital is:

Working Capital(Q: Dec. 2025 )
=(Accounts Receivable + Total Inventories + Other Current Assets) - (Accounts Payable & Accrued Expense + Defer. Rev. + Other Current Liabilities)
=(15.079 + 30.694 + 1.517) - (26.14 + 0.254 + 0)
=20.896

Working Capital(Q: Mar. 2026 )
=(Accounts Receivable + Total Inventories + Other Current Assets) - (Accounts Payable & Accrued Expense + Defer. Rev. + Other Current Liabilities)
=(14.322 + 31.294 + 1.661) - (29.252 + 0 + 0)
=18.025

When net working capital is negative, 0 is used.

Note: The EBIT data used here is four times the quarterly (Mar. 2026) EBIT data.

3. It is also linked to Joel Greenblatt's definition of Earnings Yield:

Auxly Cannabis Group's Earnings Yield (Joel Greenblatt) % for today is calculated as:

Earnings Yield (Joel Greenblatt) %=EBIT (TTM)/Enterprise Value (Q: Mar. 2026 )
=27.071/185.851
=14.57 %

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Auxly Cannabis Group EBIT Related Terms

Auxly Cannabis Group EBIT Historical Data

* Premium members only.

The historical data trend for Auxly Cannabis Group's EBIT can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Auxly Cannabis Group EBIT Chart

Auxly Cannabis Group Annual Data
Trend Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
EBIT
Get a 7-Day Free Trial Premium Member Only Premium Member Only -25.45 -84.64 -16.47 9.90 28.17

Auxly Cannabis Group Quarterly Data
Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26
EBIT Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 4.27 7.45 14.96 1.34 3.32

CBWTF vs ZTS, UTHR: EBIT Comparison

For the Drug Manufacturers - Specialty & Generic subindustry, Auxly Cannabis Group's EV-to-EBIT, along with its competitors' market caps and EV-to-EBIT data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Auxly Cannabis Group EV-to-EBIT vs Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Auxly Cannabis Group's EV-to-EBIT distribution charts can be found below:

* The bar in red indicates where Auxly Cannabis Group's EV-to-EBIT falls into.


CBWTF
36GF Score
Auxly Cannabis Group Inc CBWTF
EBIT is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Auxly Cannabis Group EBIT Calculation

EBIT, sometimes also called Earnings Before Interest and Taxes, is a measure of a firm's profit that includes all expenses except interest and income tax expenses. It is the difference between operating revenues and operating expenses. When a firm does not have non-operating income, then Operating Income is sometimes used as a synonym for EBIT and operating profit.

EBIT for the trailing twelve months (TTM) ended in Mar. 2026 adds up the quarterly data reported by the company within the most recent 12 months, which was $27.1 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about EBIT →
What does a EBIT of $27.1 Mil mean?
Auxly Cannabis Group (CBWTF) has a EBIT of $27.1 Mil as of Mar. 2026. Earnings before interest and taxes is the difference between operating revenue and operating expenses. View historical data on Auxly Cannabis Group.
Is Auxly Cannabis Group's EBIT too high?
Auxly Cannabis Group's current EBIT is $27.1 Mil. Overall, Auxly Cannabis Group has a GF Score™ of 36/100 and is considered Significantly Overvalued, reflecting its overall financial health beyond just this single metric.
How does Auxly Cannabis Group's EBIT compare to ZTS and UTHR?
Auxly Cannabis Group's EBIT of $27.1 Mil can be compared against companies in the Drug Manufacturers industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good EBIT for a Drug Manufacturers company?
A good EBIT depends on the Drug Manufacturers industry context. However, EBIT should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high EBIT mean?
A high EBIT can signal that a stock is expensive relative to its fundamentals. Earnings before interest and taxes is the difference between operating revenue and operating expenses. View historical data on Auxly Cannabis Group. Auxly Cannabis Group's current EBIT is $27.1 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Auxly Cannabis Group stock overvalued right now?
Based on GuruFocus' analysis, Auxly Cannabis Group (CBWTF) is currently considered Significantly Overvalued. The stock's GF Value™ is $0.03, compared to a current price of $0.12 — trading 308% above its estimated fair value. The current EBIT is $27.1 Mil. Auxly Cannabis Group's overall GF Score™ is 36/100 with 4 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is EBIT calculated?
EBIT is calculated from a company's financial statements. For Auxly Cannabis Group (CBWTF), the current EBIT is $27.1 Mil as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Auxly Cannabis Group (CBWTF) Overvalued in 2026?

Based on GuruFocus' analysis, Auxly Cannabis Group stock appears to be overvalued. The current stock price of $0.12 is trading 308% above its estimated GF Value™ of $0.03. GuruFocus considers Auxly Cannabis Group to be Significantly Overvalued.

Key valuation signals for CBWTF:

  • EBIT: $27.1 Mil
  • GF Value™: $0.03 vs. price of $0.12 (308% above fair value)
  • GF Score™: 36/100 with 4 warning signs

No single metric tells the full story. See the CBWTF stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

Auxly Cannabis Group Business Description

Other Exchanges 3KF:GermanyXLY:Canada
Address 777 Richmond Street West, Unit 002, Toronto, ON, CAN, M6J 0C2
Auxly Cannabis Group Inc is a consumer-packaged-goods company in the cannabis products market. The company has created a portfolio of brands designed for a broad market of cannabis consumers, with differentiation in price points across targeted consumer segments. Its product portfolio comprises dried cannabis, fresh cannabis, cannabis plants, cannabis seeds, cannabis oil, edible cannabis, cannabis extracts, and cannabis topicals, among others, which are marketed through brands like Parcel, Black Forty, Foray, Dosecann, and Kolab Project.
36GF Score

Get the complete analysis for CBWTF

EBIT is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

$0.12
Price
$0.03
GF Value